SensiVida Medical Technologies Inc., a minimally invasive bio-medical diagnostic device company, engages in the design and development of medical diagnostic instruments that detect cancer in vivo in humans. The company’s medical diagnostic instruments detects cancer in vivo in humans by using light to excite the molecules contained in tissue, and measuring the differences in the resulting fluorescence between cancerous and normal tissue. The company's proprietary optical Micro-systems based technology automates bio-sensing and data acquisition while minimizing patient discomfort. Its platform technology addresses various disease state diagnostics, such as allergy testing, pain-free automated glucose monitoring without bio-fouling, blood coagulation testing (for Coumadin patients), TB testing, and cholesterol monitoring. Products The company’s first product includes SensiVida Allergy Test system that offers painless allergy testing system. This system consists of a disposable microlancet chip/cartridge that painlessly administers the allergens; a compact imaging module/digital imager that captures real-time allergic reactions, and sends images and data to a computer; and a software that allows the user to monitor the allergic reaction and provides data regarding reaction extent, positive/negative diagnosis versus allergen, and reaction kinetics. An electronic medical record report is created, which could be printed or transmitted. The company’s second product includes an unobtrusive, wearable, or mobile glucose monitoring system with a disposable microlancet chip having individually-monitored sensors that are actuated in accordance to the patient’s test schedule. At user-defined time intervals, each needle of the array is deployed by an actuator and inserted into the patient’s skin. The fine tips of each microlancet are coated with a glucose sensitive enzyme (glucose oxidase) that is optically or electrically read out by system electronics. The data are calibrated so as to represent actual glucose concentrations and displayed, stored, or transmitted depending on the application. Partnerships In 2010, the company established a partnership with Wi Inc., which develops biomedical devices. Under this partnership, Wi Inc. would provide design and prototype development for the disposable allergen delivery component of the allergy test system. In 2010, the company established a partnership with Dhurjaty Electronics Consulting, LLC for the development of its digital allergy testing module. The company has also established a partnership with MDC Associates, a consulting firm that specializes in clearance and compliance, clinical study design and management, establishing company quality systems documentation for regulatory compliance, , developing pre-market submissions, and facility audits. After product launch, MDC would provide customer support services, including its call center and over-the-phone training. History SensiVida Medical Technologies Inc. was founded in 1971.
sensivida medical technologi
150 Lucius Gordon Drive
West Henrietta, NY 14586
|No competitor information is available for SVMT.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
Sponsored Financial Commentaries
To contact SENSIVIDA MEDICAL TECHNOLOGI, please visit www.sensividamedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.